Tell a friend
(Mandatory)
(Mandatory)
(Mandatory)
(Mandatory)

EPF Acknowledgement of financial support 2015

2015 Accounts

   
     
Acknowledgement of Financial Support (1)
    % of total income
EPF wishes to thank the European Commission for its support in 2015 in relation to EPF's role in the following projects:    
Adapt Smart 11,693.07 € 0.6%
JA CHRODIS 19,600.00 € 1.1%
JA PASQ 18,680.02 € 1.0%
SmartCare 6,551.93 € 0.4%
PISCE Self Care Tender 21,601.06 € 1.2%
We Care 18,934.51 € 1.0%
     

EPF wishes to thank the following donors for their support:

     
Operational work programme     
European Commission (Executive Agency for Health and Consumers) 728,212.00 € 39.1%
Almirall 20,000.00 € 1.1%
Baxter 10,000.00 € 0.5%
Gilead 20,000.00 € 1.1%
GSK 30,000.00 € 1.6%
MSD 16,100.00 € 0.9%
Pfizer 20,000.00 € 1.1%
F.Hoffmann-La Roche 15,000.00 € 0.8%
Sanofi Pasteur MSD 20,000.00 € 1.1%
TEVA 20,000.00 € 1.1%
Membership 11,000.00 € 0.6%
     

Capacity building programme

 
Biogen IDEC International GmbH 20,000.00 € 1.1%
GSK 30,000.00 € 1.6%
Janssen 30,000.00 € 1.6%
Lilly 15,000.00 € 0.8%
Novartis  35,000.00 € 1.9%
Philips 25,000.00 € 1.3%
Sandoz 10,000.00 € 0.5%
     

The European Patients' Academy on Therapeutic Innovation Public Private Partnership (EUPATI)

   
Innovative Medicine Initiative (IMI JU) contribution 262,397.62 € 14.1%
Industry consortium (Hoffman La Roche, Genzyme, Boehringer, VFA, GSK, AMGEN, ESTVE, Novonordis, S.A. Eli Lilly, Novartis, Astra Zeneca, Bayer, UCB, CHIESI, Janssen, Merck) 60,856.11 € 3.3%
     

Project Portfolio

   
Abbvie 25,000.00 € 1.3%
Amgen 35,000.00 € 1.9%
CSL Behring 10,000.00 € 0.5%
Grünenthal 10,000.00 € 0.5%
Hospira Benelux BVBA 25,000.00 € 1.3%
MSD 13,900.00 € 0.7%
Sanofi-Aventis 40,000.00 € 2.1%
Servier 10,000.00 € 0.5%
Shire 5,000.00 € 0.3%
     

Empowerment Campaign

   
Amgen 15,000.00 € 0.8%
Bosch Foundation 125,000.00 € 6.7%
GSK 30,000.00 € 1.6%
     
     

Memberships and other income

22,202.73 € 1.2%
     
Total income 1,861,728.65 € 100.0%
     
Accruals and deferrals (1) 89,475.84 €  
     
Total income net of adjustments 1,951,204.49 €  
     
(1) In accordance with generally accepted accounting principles,  funding received in-year is subject to accrual and deferral adjustments proportionate to the level of resources assigned to pluriannual activities and projects. In 2015, this method had the effect of an increase of total income by € 89.475,84